SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon.

GIFT Nifty ended 22 points or 0.08% down at 25,984.50 indicating a negative opening for domestic indices NSE Nifty 50 and BSE ...

The UT administration's Drugs Control Wing conducted extensive raids on chemist shops in Manimajra, uncovering violations including unlicensed drug sales and absence of qualified pharmacists.

The Almac Group in Craigavon has confirmed an £11m investment to expand its global analytical services capabilities in a move ...

The boss of a fast-growth Belfast technology and data analytics specialist has set out his ambition to float the company on ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Nearly 300 stocks, including JSW Steel and NTPC, reached one-year highs on the BSE, despite the Sensex and Nifty 50 falling ...

Healthcare drug developers have found that AI machine learning models have cut their discovery process down by 70% to 80%.

Patient-reported quality of life (QoL) was similar between proton beam therapy (PBT) and intensity-modulated radiation ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

Family Heart Foundation unveiled the Cholesterol Connect program for LDL-C Awareness Day, aiming to make it easier for people ...

Astellas Pharma is slowing things down in the inaugural consumer-facing marketing blast for eye disease drug Izervay. | ...